Fundraising Fox
Dash Bio
Boston, US · Founded 2024 · Delaware corporation · 43 employees on LinkedIn · 8 known investors
Find your way into Dash Bio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Thomas Cuvelier to introduce you to Dave Johnson
You →Thomas · together at Dash Bio →Dave
Sign up to find every way you can get introduced to Dash Bio
- Your email: who you already know at Dash Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Dash Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
Founders & leadership
Dash Bio was founded in 2024 by Dave Johnson.
Board
Investors · 8
How we know: Companion M Gmb H's portfolio page · Not right? Tell us
How we know: Cybernetix Ventures's portfolio page · Not right? Tell us
How we know: LifeX Ventures's portfolio page · Not right? Tell us
How we know: Oak HC/FT's portfolio page · offering press articles · funding news · endpoints.news · Not right? Tell us
How we know: Swift Ventures's portfolio page · Not right? Tell us
How we know: offering press articles · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.1M disclosed across 3 rounds · 2024–2026
▶$30MraisedJul 2026 · 9 investors · Other Health CareRule 506(b)
- David JohnsonExecutive Officer, Director
- Alexander TallettExecutive Officer, Director
- Andy SmithDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$11MraisedJun 2025 · 12 investors · BiotechnologyRule 506(b)
- ALEXANDER TALLETTExecutive Officer, Director
- DAVID JOHNSONExecutive Officer, Director
- Amount sold
- $11M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$6.1MraisedOct 2024 · 15 investors · BiotechnologyRule 506(b)
- DAVID JOHNSONExecutive Officer, Director
- ALEXANDER TALLETTExecutive Officer, Director
- Amount sold
- $6.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Dash Bio.
In the news
Frequently asked questions
- What does Dash Bio do?
- Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
- Who founded Dash Bio?
- Dash Bio was founded by Dave Johnson in 2024.
- Who are Dash Bio's investors?
- Dash Bio's investors include Companion M Gmb H, Cybernetix Ventures, LifeX Ventures, Oak HC/FT, Swift Ventures, Freestyle Capital, Kindred Capital, RTP Global.
- How much funding has Dash Bio raised?
- Dash Bio has disclosed $47.1M raised across 3 rounds.
- Where is Dash Bio headquartered?
- Dash Bio is headquartered in Boston, US.